Recital 10, Regulation (EU) 2024/2052

In forcesince 30 Jul 2024

For a non-allowed pharmacologically active substance, validation of a concentration of 0,5 times the reference points per action (RPA) is requested. However, sometimes it is not reasonably achievable as the concentration is too low from the analytical point of view and, therefore, the concentration of 0,5 times the RPA can be replaced by the lowest concentration between 0,5 times and 1,0 times the RPA, which is reasonably achievable. For some cases, the lowest calibrated level can be lower than 0,5 times the RPA and therefore the possibility of validation at this concentration level should be added into the relevant footnotes.